skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 591,306  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: Database: GFMER Free Medical Journals remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Risks and cancer associations of metachronous and synchronous multiple primary cancers: a 25-year retrospective study
Material Type:
Article
Add to My Research

Risks and cancer associations of metachronous and synchronous multiple primary cancers: a 25-year retrospective study

BMC cancer, 2021-09, Vol.21 (1), p.1-1045, Article 1045 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-08766-9 ;PMID: 34556087

Full text available

2
Smoking, alcohol consumption, and cancer: A mendelian randomisation study in UK Biobank and international genetic consortia participants
Material Type:
Article
Add to My Research

Smoking, alcohol consumption, and cancer: A mendelian randomisation study in UK Biobank and international genetic consortia participants

PLoS medicine, 2020-07, Vol.17 (7), p.e1003178 [Peer Reviewed Journal]

COPYRIGHT 2020 Public Library of Science ;COPYRIGHT 2020 Public Library of Science ;2020 Larsson et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Larsson et al 2020 Larsson et al ;ISSN: 1549-1676 ;ISSN: 1549-1277 ;EISSN: 1549-1676 ;DOI: 10.1371/journal.pmed.1003178 ;PMID: 32701947

Full text available

3
Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature
Material Type:
Article
Add to My Research

Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature

PloS one, 2012-12, Vol.7 (12), p.e50946-e50946 [Peer Reviewed Journal]

COPYRIGHT 2012 Public Library of Science ;COPYRIGHT 2012 Public Library of Science ;2012 Zhang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2012 Zhang et al 2012 Zhang et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0050946 ;PMID: 23284651

Full text available

4
Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review
Material Type:
Article
Add to My Research

Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review

PloS one, 2013-08, Vol.8 (8), p.e71583 [Peer Reviewed Journal]

COPYRIGHT 2013 Public Library of Science ;COPYRIGHT 2013 Public Library of Science ;2013 Franciosi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2013 Franciosi et al 2013 Franciosi et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0071583 ;PMID: 23936520

Full text available

5
Cancer statistics, 2022
Material Type:
Article
Add to My Research

Cancer statistics, 2022

CA: a cancer journal for clinicians, 2022-01, Vol.72 (1), p.7-33 [Peer Reviewed Journal]

2022 The Authors. published by Wiley Periodicals LLC on behalf of American Cancer Society ;2022 The Authors. CA: A Cancer Journal for Clinicians published by Wiley Periodicals LLC on behalf of American Cancer Society. ;Copyright Wiley Subscription Services, Inc. Jan/Feb 2022 ;ISSN: 0007-9235 ;EISSN: 1542-4863 ;DOI: 10.3322/caac.21708 ;PMID: 35020204

Full text available

6
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
Material Type:
Article
Add to My Research

PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer

Molecular cancer, 2023-08, Vol.22 (1), p.1-138, Article 138 [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;BioMed Central Ltd., part of Springer Nature 2023 ;ISSN: 1476-4598 ;EISSN: 1476-4598 ;DOI: 10.1186/s12943-023-01827-6 ;PMID: 37596643

Full text available

7
PD-1 blockade inhibits osteoclast formation and murine bone cancer pain
Material Type:
Article
Add to My Research

PD-1 blockade inhibits osteoclast formation and murine bone cancer pain

The Journal of clinical investigation, 2020-07, Vol.130 (7), p.3603-3620 [Peer Reviewed Journal]

COPYRIGHT 2020 American Society for Clinical Investigation ;COPYRIGHT 2020 American Society for Clinical Investigation ;Copyright American Society for Clinical Investigation Jul 2020 ;2020 American Society for Clinical Investigation 2020 American Society for Clinical Investigation ;ISSN: 0021-9738 ;EISSN: 1558-8238 ;DOI: 10.1172/jci133334 ;PMID: 32484460

Full text available

8
Risk of second primary cancers after a diagnosis of first primary cancer: A pan-cancer analysis and Mendelian randomization study
Material Type:
Article
Add to My Research

Risk of second primary cancers after a diagnosis of first primary cancer: A pan-cancer analysis and Mendelian randomization study

eLife, 2023-11, Vol.12 [Peer Reviewed Journal]

2023, Ruan, Huang et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023, Ruan, Huang et al 2023 Ruan, Huang et al ;ISSN: 2050-084X ;EISSN: 2050-084X ;DOI: 10.7554/eLife.86379 ;PMID: 37917154

Full text available

9
Cancer statistics, 2023
Material Type:
Article
Add to My Research

Cancer statistics, 2023

CA: a cancer journal for clinicians, 2023-01, Vol.73 (1), p.17-48 [Peer Reviewed Journal]

2023 The Authors. CA: A Cancer Journal for Clinicians published by Wiley Periodicals LLC on behalf of American Cancer Society. ;Copyright Wiley Subscription Services, Inc. Jan/Feb 2023 ;ISSN: 0007-9235 ;EISSN: 1542-4863 ;DOI: 10.3322/caac.21763 ;PMID: 36633525

Full text available

10
Correction to: Managing Ibrutinib-Intolerant Patients With B-Cell Malignancies
Material Type:
Article
Add to My Research

Correction to: Managing Ibrutinib-Intolerant Patients With B-Cell Malignancies

The oncologist (Dayton, Ohio), 2023-06, Vol.28 (6), p.e487-e487 [Peer Reviewed Journal]

The Author(s) 2023. Published by Oxford University Press. 2023 ;COPYRIGHT 2023 Oxford University Press ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1093/oncolo/oyad048 ;PMID: 36821849

Full text available

11
Elevated serum CA199 levels in patients suffering type 2 diabetes vs. various types of cancer
Material Type:
Article
Add to My Research

Elevated serum CA199 levels in patients suffering type 2 diabetes vs. various types of cancer

BMC endocrine disorders, 2024-01, Vol.24 (1), p.9-5, Article 9 [Peer Reviewed Journal]

2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1472-6823 ;EISSN: 1472-6823 ;DOI: 10.1186/s12902-024-01539-y ;PMID: 38212751

Full text available

12
Correction to: Cancer incidence in Khyber Pakhtunkhwa, Pakistan, 2020
Material Type:
Article
Add to My Research

Correction to: Cancer incidence in Khyber Pakhtunkhwa, Pakistan, 2020

BMC public health, 2023-10, Vol.23 (1), p.1-1974, Article 1974 [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;BioMed Central Ltd., part of Springer Nature 2023 ;ISSN: 1471-2458 ;EISSN: 1471-2458 ;DOI: 10.1186/s12889-023-16888-x ;PMID: 37821858

Full text available

13
Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy
Material Type:
Article
Add to My Research

Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy

Journal of hematology and oncology, 2019-05, Vol.12 (1), p.54-54, Article 54 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1756-8722 ;EISSN: 1756-8722 ;DOI: 10.1186/s13045-019-0738-1 ;PMID: 31151482

Full text available

14
EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group
Material Type:
Article
Add to My Research

EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group

BMC cancer, 2019-05, Vol.19 (1), p.494-494, Article 494 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-5675-4 ;PMID: 31126258

Full text available

15
Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT
Material Type:
Article
Add to My Research

Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT

Molecular cancer, 2019-03, Vol.18 (1), p.40-40, Article 40 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;Copyright © 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1476-4598 ;EISSN: 1476-4598 ;DOI: 10.1186/s12943-019-0959-5 ;PMID: 30866952

Full text available

16
TIM-3, a promising target for cancer immunotherapy
Material Type:
Article
Add to My Research

TIM-3, a promising target for cancer immunotherapy

OncoTargets and therapy, 2018-01, Vol.11, p.7005-7009 [Peer Reviewed Journal]

COPYRIGHT 2018 Dove Medical Press Limited ;COPYRIGHT 2018 Dove Medical Press Limited ;2018. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 He et al. This work is published and licensed by Dove Medical Press Limited 2018 ;ISSN: 1178-6930 ;EISSN: 1178-6930 ;DOI: 10.2147/ott.s170385 ;PMID: 30410357

Full text available

17
Correction to: The function and mechanisms of action of circular RNAs in Urologic Cancer
Material Type:
Article
Add to My Research

Correction to: The function and mechanisms of action of circular RNAs in Urologic Cancer

Molecular cancer, 2023-04, Vol.22 (1), p.73-73, Article 73 [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 1476-4598 ;EISSN: 1476-4598 ;DOI: 10.1186/s12943-023-01774-2 ;PMID: 37095498

Full text available

18
Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway
Material Type:
Article
Add to My Research

Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway

Molecular cancer, 2019-02, Vol.18 (1), p.20-20, Article 20 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;Copyright © 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1476-4598 ;EISSN: 1476-4598 ;DOI: 10.1186/s12943-018-0935-5 ;PMID: 30717751

Full text available

19
Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer
Material Type:
Article
Add to My Research

Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer

Molecular cancer, 2019-03, Vol.18 (1), p.68-68, Article 68 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1476-4598 ;EISSN: 1476-4598 ;DOI: 10.1186/s12943-019-0972-8 ;PMID: 30927911

Full text available

20
Exosome-based immunotherapy: a promising approach for cancer treatment
Material Type:
Article
Add to My Research

Exosome-based immunotherapy: a promising approach for cancer treatment

Molecular cancer, 2020-11, Vol.19 (1), p.1-160, Article 160 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1476-4598 ;EISSN: 1476-4598 ;DOI: 10.1186/s12943-020-01278-3 ;PMID: 33183286

Full text available

Results 1 - 20 of 591,306  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (542,742)

Refine My Results

Creation Date 

From To
  1. Before 1960  (404)
  2. 1960 To 1975  (578)
  3. 1976 To 1991  (3,724)
  4. 1992 To 2008  (71,184)
  5. After 2008  (515,193)
  6. More options open sub menu

Subject 

  1. Science & Technology  (481,618)
  2. Life Sciences & Biomedicine  (414,024)
  3. Humans  (289,110)
  4. Cancer  (222,288)
  5. Oncology  (202,518)
  6. Female  (144,924)
  7. Tumors  (142,717)
  8. Male  (105,882)
  9. Breast Cancer  (91,135)
  10. Middle Aged  (88,912)
  11. Patients  (85,343)
  12. Cancer Therapies  (82,440)
  13. Proteins  (77,907)
  14. Animals  (75,938)
  15. Metastasis  (75,921)
  16. Aged  (73,030)
  17. Care And Treatment  (72,451)
  18. Health Aspects  (72,160)
  19. Chemotherapy  (71,381)
  20. Science & Technology - Other Topics  (68,373)
  21. More options open sub menu

Language 

  1. English  (586,756)
  2. Japanese  (98,712)
  3. Portuguese  (3,919)
  4. Spanish  (3,255)
  5. Korean  (877)
  6. French  (827)
  7. Turkish  (654)
  8. Norwegian  (450)
  9. Chinese  (327)
  10. Persian  (122)
  11. Croatian  (108)
  12. Polish  (101)
  13. German  (90)
  14. Russian  (85)
  15. Latvian  (50)
  16. Afrikaans  (33)
  17. Italian  (27)
  18. Arabic  (10)
  19. Slovak  (8)
  20. Czech  (8)
  21. More options open sub menu

Searching Remote Databases, Please Wait